The FDA’s refuse-to-file letter cited no safety or efficacy concerns for Moderna’s influenza vaccine, mRNA-1010. The company said the agency’s justification for refusing a review is inconsistent with guidance given prior to the start of Phase 3 testing. The post Moderna Says FDA Refusal to Review mRNA Flu Vaccine Contradicts Federal Rules, Prior Guidance appeared…
AI can help health plans reduce friction, speed revenue-cycle throughput, and improve member experience, but only when it is deployed with strong data discipline, modern integration patterns, and a governance model that treats AI as “augmented intelligence,” meaning powerful, assistive, and accountable. The post From Claims Payer to Care Partner: What AI Really Changes in…
[Sponsored] Patient care improves when people get accurate test results from an excellent diagnostic company. The post This Diagnostic Company Is Rapidly Expanding in Emerging Markets: What to Know appeared first on MedCity News.
Healthcare cannot achieve its goals for quality, equity, and value without breaking down the persistent barriers that keep critical information siloed across sectors. The post The Next Frontier of Interoperability: Additional Clinical Data Sources – Dentistry, Devices, Social Care, and More appeared first on MedCity News.
The challenge for policymakers is balance: encouraging rigor without unintentionally weakening a program that now serves the majority of Medicare beneficiaries. Thoughtful rate calibration can determine whether this transition strengthens the program or strains it unnecessarily. The post Medicare Advantage’s Discipline Era — and Why the Final Rate Notice Matters More Than It Appears appeared…
Evommune’s EVO301 met the goals of a placebo-controlled Phase 2a study in atopic dermatitis. The biologic drug neutralizes a signaling protein involved in multiple inflammatory pathways, which could differentiate it from the blockbuster Sanofi and Regeneron Pharmaceuticals immunology drug Dupixent. The post Evommune Starts Making Case to Challenge Dominance of Sanofi’s Dupixent in Atopic Dermatitis…
Elli Lilly has been in the news lately because of the announced $1 billion investment in a joint innovation lab with Nvidia, an AI powerhouse player. But AI drug discovery is only part of the story of where AI can be leveraged in biopharma. The post Lilly’s Chief Information & Digital Officer: AI Use Goes…
Health advocate network Solace Health gained unicorn status after closing a $130 million Series C funding round. The startup’s advocates help with tasks like scheduling appointments, finding in-network providers, understanding insurance coverage and bills, and coordinating care across multiple clinicians. And they actually handle much of the work on a patient’s behalf, rather than simply…
Speed still matters, but there’s been a shift in the industry. It’s not enough to be scientifically sound. Now, practicality is of utmost importance. The post From Pandemic Urgency to Practical Impact: How Diagnostics Investment Priorities Are Evolving appeared first on MedCity News.
[Sponsored] Surfaces can appear clean to the naked eye while still harboring dangerous levels of microscopic organic material. The post Top ATP Tests for Effective Sanitation and Hygiene Monitoring appeared first on MedCity News.